On April 5, 2010
If Pfizer Wants Mylan, It’ll Get a Can of Worms As Well
Pfizer (PFE) may want to think carefully before acquiring generics maker Mylan (MYL), as the company has a number of problems that won’t be easily sorted out. Mylan’s stock is still up around the $23 on rumors that Pfizer is
…
0 Comments